Becton, Dickinson and Company (BDX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Franklin Lakes, NJ, United States. El CEO actual es Thomas E. Polen Jr..
BDX tiene fecha de IPO 1973-02-21, 70,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $56.42B.
Becton, Dickinson and Company is a global medical technology manufacturer founded in 1897 that develops and sells medical supplies, devices, laboratory equipment, and diagnostic products serving healthcare institutions, physicians, life science researchers, clinical laboratories, and pharmaceutical companies worldwide. The company operates through three primary segments: BD Medical, which provides infusion therapy systems, medication management solutions, and diabetes care products; BD Life Sciences, which offers blood collection, microbiology automation, and cellular analysis systems; and BD Interventional, which supplies surgical instruments, grafts, and critical care products. With headquarters in Franklin Lakes, New Jersey, the company delivers comprehensive solutions across medical device manufacturing, laboratory diagnostics, and clinical interventions.
